Nurse Practitioners and Physician Assistants: The Front-Line in the Diagnosis of Bipolar Disorder
neuroscienceCME Webcast
Premiere Date: Thursday, January 7, 2016This activity offers CE credit for:
- Physicians (CME)
- Psychologists (APA)
- Nurse Practitioners (AANP)
- Physician Assistants (AAPA)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Saturday, January 7, 2017
Note: Credit Is No Longer Available
 | Charles B. Nemeroff, MD, PhD Professor and Chair Department of Psychiatry Mulva Clinic for the Neurosciences Director, Institute of Early Life Adversity Research Dell Medical School The University of Texas at Austin Austin, TX |
 | Mary D. Moller, DNP, ARNP, PMHCNS-BC, CPRP, FAAN Associate Professor Pacific Lutheran University School of Nursing Director of Psychiatric Services Northwest Center for Integrated Health Tacoma, WA |
Bipolar disorder is characterized by the cyclical occurrence of elevated (manic or hypomanic) and depressed mood states. The illness, which includes the bipolar I and bipolar II subtypes, exacts a heavy toll in terms of quality of life, functioning, morbidity, comorbidity, and mortality.1 A special challenge for diagnosis and treatment is bipolar depression.
A number of studies suggest that patients with bipolar disorder are often misdiagnosed on initial presentation, and most often with major depressive disorder. Treatment of these patients may be ineffective or possibly worsen outcomes by precipitating symptoms of mania or hypomania. Reasons may include incomplete history, lack of patient reporting an accurate history, or the presence of psychiatric comorbidity, such as anxiety or substance use disorders.2
Education to front-line nurse practitioners, and physician assistants in both psychiatric and primary care settings can help to sharpen diagnostic skills and improve treatment choices, as well as the therapeutic relationship with bipolar patients and their families.
In this neuroscienceCME live activity, learners will be able to engage in real time with expert faculty and their peers to gain broader insights into the diagnosis and treatment of bipolar depression.
- Judd LL, Akiskal HS, Schettler PJ, et al. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry. 2005;62(12):1322-1330. PMID: 16330720.
- Perlis RH. Misdiagnosis of bipolar disorder. Am J Manag Care. 2005;11(9 Suppl):S271-S274. PMID: 16232009.
Module 1: Nurse Practitioners and Physician Assistants: The Front-Line in the Diagnosis of Bipolar Disorder Click here to begin this activity now
Module 2: Nurse Practitioners and Physician Assistants: The Front-Line in the Treatment and Clinical Management of Bipolar Disorder Click here to access this activity
Module 3: Nurse Practitioners and Physician Assistants: The Front-Line in the Management of Bipolar Disorder and Metabolic Sequelae Click here to access this activity
Each module is certified for .5 AMA PRA Category 1 Credit™. We encourage participants to complete all three modules to optimize the learning experience.
At the end of this CE activity, participants should be able to:
- Describe the differential diagnosis of bipolar disorder and delineate bipolar I from bipolar II disorder and unipolar from bipolar depression.
Supported by an educational grant from Sunovion Pharmaceuticals Inc.
Nurse practitioners, physician assistants, and other health care professionals treating patients with bipolar disorder.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this live activity for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP Credit (Nurse Practitioners):
This program is approved for 0.45 contact hour(s) of continuing education by the American Association of Nurse Practitioners. Program ID 15111977. This program was planned in accordance with AANP CE Standards and Policies.
AAPA Credit (Physician Assistants):
This program has been reviewed and is approved for a maximum of 0.50 hours of AAPA Category 1 CME credit by the Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity.
This program was planned in accordance with AAPA's CME Standards for Live Programs and for Commercial Support of Live Programs.
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST19052 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Nemeroff has disclosed that he receives grants/research support from the National Institutes of Health (NIH). He serves as a consultant to Bracket (Clintara); Gerson Lehrman Group, Inc. (GLG) Healthcare & Biomedical Council; Lundbeck; Mitsubishi Tanabe Pharma Development America; Prismic Pharmaceuticals, Inc.; Taisho Pharmaceutical Inc.; Takeda Pharmaceuticals North America, Inc.; Total Pain Solutions (TPS); and Xhale, Inc. He serves on the scientific advisory boards of the American Foundation for Suicide Prevention (AFSP); Anxiety Disorders Association of America (ADAA); Bracket (Clintara);Brain & Behavior Research Foundation (BBRF) (formerly National Alliance for Research on Schizophrenia and Depression [NARSAD]); Clintara; RiverMend Health, LLC; Skyland Trail; and Xhale, Inc. He serves on the board of directors of the American Foundation for Suicide Prevention (AFSP); Anxiety Disorders Association of America (ADAA); and GratitudeAmerica, Inc. He is a stockholder of AbbVie Inc,; Bracket (Clintara); Celgene Corporation; COPKO Health, Inc.; Seattle Genetics, Inc.; Titan Pharmaceuticals, Inc.; and Xhale, Inc. His other financial income sources or equity of $10,000 or more include American Psychiatric Publishing; Bracket (Clintara); CME Outfitters, LLC; Takeda Pharmaceuticals North America, Inc.; Xhale, Inc. Dr. Nemeroff has patients for method and devices for transdermal delivery of lithium (US 6,375,990B1); method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2).
Dr. Moller serves on the advisory board of Otsuka America Pharmaceuticals. She is on the speakers bureau of Alkermes.
Tony Graham, MD (peer reviewer) has no disclosures to report.
Scott Richards, PhD, PA-C, DFAAPA (peer reviewer) has no disclosures to report.
Robert Kennedy (planning committee) has no disclosures to report.
Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
CME Outfitters, LLC, the faculty, and Sunovion Pharmaceuticals Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
WC-024-010716-23
